Freedman D, Dandona P, Fernando O, Moorhead J F
J Clin Pathol. 1982 Jul;35(7):737-9. doi: 10.1136/jcp.35.7.737.
Haemoglobin A1 (HbA1) was determined by ion-exchange chromatography in 37 normoglycaemic patients with chronic renal failure (CRF) and 26 with successful renal transplants. Blood glucose concentrations in patients with CRF were similar to those in controls, and there was a significant correlation between fasting blood glucose concentration and HbA1 in these groups. HbA1 in patients with CRF was, however, significantly lower than that in control subjects. Concentrations of HbA1 in patients on haemodialysis, peritoneal dialysis, and those with steady state CRF prior to dialysis were not significantly different from each other. Whereas patients with successful renal transplants of greater than 3 months' duration had HbA1 concentrations indistinguishable from controls, HbA1 in patients with transplants of shorter duration were significantly lower. These observations are suggestive of a shortened erythrocyte survival in CRF per se. Furthermore, these results indicate: (a) the inadequacy of HbA1 in monitoring the quality of diabetic control in patients with CRF, and (b) the absence of a specific effect of dialysis on HbA1, and the restoration to normal HbA1 after successful renal transplantation.
采用离子交换色谱法测定了37例慢性肾功能衰竭(CRF)的血糖正常患者和26例肾移植成功患者的血红蛋白A1(HbA1)。CRF患者的血糖浓度与对照组相似,且这些组中空腹血糖浓度与HbA1之间存在显著相关性。然而,CRF患者的HbA1显著低于对照组。血液透析患者、腹膜透析患者以及透析前处于稳定状态的CRF患者的HbA1浓度彼此之间无显著差异。肾移植成功且持续时间超过3个月的患者,其HbA1浓度与对照组无明显差异,而移植时间较短的患者的HbA1则显著较低。这些观察结果提示CRF本身存在红细胞存活期缩短的情况。此外,这些结果表明:(a)HbA1在监测CRF患者糖尿病控制质量方面存在不足;(b)透析对HbA1没有特定影响,且肾移植成功后HbA1恢复正常。